Efficiency of Vaccination with Lysate-loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma

NCT03395587 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

136

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

BIOLOGICAL: Autologous, tumor lysate-loaded, mature dendritic cells (DC)
DRUG: standard therapy

Sponsor

Heinrich-Heine University, Duesseldorf

Collaborators

[object Object]